Zoetis (NY:ZTS)

69.69 UNCHANGED

Delayed Quote Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Zoetis

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

29 30 Next >

Animal Health Giant Zoetis Stock Crumbles: Possible Side Effect Of Its Pet Arthritis Pain Drugs Sickened Dogs, Cats ↗

April 12, 2024

Zoetis' Solensia and Librela, pioneering arthritis treatments for pets. Despite recent concerns, Zoetis defends their safety record, emphasizing positive outcomes for millions of treated animals.

Via Benzinga

A Closer Look at Zoetis's Options Market Dynamics ↗

April 12, 2024

Via Benzinga

Zoetis Stock Crumbles After Report Suggests Arthritis Shots Sickened Dogs, Cats ↗

April 12, 2024

The company says the side effects represent a fraction of the 18 million injections given in the U.S. and abroad.

Via Investor's Business Daily

(ZTS) - Analyzing Zoetis's Short Interest ↗

April 10, 2024

Via Benzinga

How's AT&T Handling Things? ↗

April 09, 2024

We've also got a look at 3M's spinoff, gold prices, and the beef industry.

Via The Motley Fool

Expert Outlook: Zoetis Through The Eyes Of 4 Analysts ↗

April 02, 2024

Via Benzinga

Here's How Much You Would Have Made Owning Zoetis Stock In The Last 10 Years ↗

March 28, 2024

Via Benzinga

Here's How Much $100 Invested In Zoetis 10 Years Ago Would Be Worth Today ↗

March 19, 2024

Via Benzinga

Looking Into Zoetis's Recent Short Interest ↗

March 08, 2024

Via Benzinga

Zoetis Appoints Gavin D.K. Hattersley to its Board of Directors

April 01, 2024

From Zoetis Inc.

Via Business Wire

Is It Time to Buy the S&P 500's 3 Worst-Performing Stocks of March? ↗

April 01, 2024

The S&P 500 rose last month, but these stocks didn't.

Via The Motley Fool

Topics Stocks

Zoetis to Host Webcast and Conference Call on First Quarter 2024 Financial Results

March 28, 2024

From Zoetis Inc.

Via Business Wire

4 Analysts Have This To Say About Zoetis ↗

February 20, 2024

Via Benzinga

(ZTS) - Analyzing Zoetis's Short Interest ↗

February 14, 2024

Via Benzinga

Is ZOETIS INC (NYSE:ZTS) a Strong Candidate for Quality Investing? ↗

February 12, 2024

Why Quality Investors Should Delve into ZOETIS INC (NYSE:ZTS) for Investment Opportunities.

Via Chartmill

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,100 Today ↗

February 01, 2024

Via Benzinga

Largest Animal Health Firm Zoetis Hit With European Probe Over Possible Breach of Competition Rules Related To Dog Pain Medicine ↗

March 27, 2024

The European Commission launches probe into Zoetis over alleged market interference in dog pain medication launch. Focus on Zoetis' Librela monoclonal antibody for osteoarthritis pain relief in dogs...

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

March 18, 2024

Via Benzinga

Zoetis to Participate in the Barclays Global Healthcare Conference

March 05, 2024

From Zoetis Inc.

Via Business Wire

1 Magnificent S&P 500 Dividend Stock Down 23% to Buy Right Now ↗

February 26, 2024

Buoyed by megatrends in animal healthcare, this stock makes for an excellent holding in almost any portfolio.

Via The Motley Fool

Topics Stocks

Zoetis to Participate in the Bank of America Securities 2024 Animal Health Summit

February 21, 2024

From Zoetis Inc.

Via Business Wire

Zoetis (ZTS) Q4 2023 Earnings Call Transcript ↗

February 13, 2024

ZTS earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

Markets Tumble, VIX Up 8% On Hot Inflation Data, Dollar, Yields Jump As Traders Unwind Rate Cut Bets: What's Driving Markets Tuesday? ↗

February 13, 2024

Wall Street witnessed one of the worst sessions since the beginning of the year, with widespread declines across the board as stocks were hit by the impact of a higher-than-expected inflation report.

Via Benzinga

Topics Economy Stocks

Animal Health-Focused Zoetis Stock Faces Near-Term Pressure, Analyst Cites Uncertainty In Q4 Results, Weak Margins ↗

February 13, 2024

Zoetis' Q4 2023 performance with $2.21 billion revenue, 8% YoY growth, and strong sales in companion animal products.

Via Benzinga

Zoetis Reports Fourth Quarter and Full Year 2023 Results

February 13, 2024

From Zoetis Inc.

Via Business Wire

Zoetis Declares Second Quarter 2024 Dividend

February 06, 2024

From Zoetis Inc.

Via Business Wire

Drug Maker AbbVie Stock Sees RS Rating Jump To 81 ↗

February 05, 2024

AbbVie stock saw a welcome improvement to its Relative Strength (RS) Rating on Monday, with an increase from 78 to 81.

Via Investor's Business Daily

Earnings Scheduled For February 13, 2024 ↗

February 13, 2024

Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on revenue of $838.27 million.

Via Benzinga

Novo Nordisk Stock Just Earned A 92 RS Rating; Gapped Up On Earnings ↗

February 01, 2024

Novo Nordisk ADR sees its Relative Strength Rating move into the elite 90-plus level.

Via Investor's Business Daily

Paws And Prosperity: Exploring U.S. Pet Services Growth And The Anticipated Surge In Annual Pet Spending From $980 To $1,292 By 2025 ↗

January 30, 2024

The number of U.S. homes with pets has been trending upward for decades, with more than 5 million more pets in the U.S. than before the pandemic. Beyond the pandemic-driven boom, the trends continue,...

Via Benzinga

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

29 30 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.